The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: NRC

Monday Biotech Deal Review: September 19, 2011

Welcome to your Monday Biotech Deal Review for September 19, 2011.  Of note in the past week was the extension of the hostile bid by Paladin Labs of Afexa Life Sciences to September 28th, the application by Merus to graduate to the TSXV, and the filing by Allon Therapeutics of a short-form preliminary prospectus.  Read [...]

Monday Biotech Deal Review: July 12, 2010

This week saw several interesting deals, including an $85+ million exit for Sentinelle, some “bio-bucks” made good for Cipher, a licensing deal for Amorfix’s vCJD technology, a $10 million malaria deal for BC-based Artepharm and a new name (Medwell Capital) to go along with BioMS’ new business model.

PubMed Central Comes to Canada (or vice-versa?)

If you ever read scientific publications, but you don’t have institutional journal subscriptions, you definitely know and love PubMed Central, the U.S. National Library of Medicine’s (NLM) online repository of free-access full-text papers. Well, get ready for So You Think You Can Publish Canada PubMed Central Canada! CIHR and the NRC’s Canada Institute for Scientific [...]

Monday Deal Review: June 29, 2009

This week’s Monday Deal Review has a full set of equity deals from shelf to launch to close, one new U.S. registration and one deregistration to match, and some ideas for what to do with your debt (!), all

Follow

Get every new post delivered to your Inbox.

Join 84 other followers